drugset / Trial / NCT01964014

Once-a-day Immunosuppression(CISECON_a_day)

NCT01964014

Phase 4 Completed 160 enrolled Ajou University School of Medicine
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to assess the efficacy and safety and Immunosuppressant Therapy Barrier Scale (ITBS) of once daily immunosuppressant maintenance therapy in patients who had kidney transplantations earlier.

Timeline

Start
2013-10
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Sirolimus Small molecule
Subject advagrf Unknown